stockportfolio.pro
Corteva, Inc. (CTVA)
Basic Materials · Agricultural Inputs · NYSE
Corteva, Inc. revenue & earnings — last 8 fiscal years
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $14.29B | $13.85B | $14.22B | $15.65B | $17.45B | $17.23B | $16.91B | $17.40B |
| Gross profit | $4.34B | $5.27B | $5.71B | $6.43B | $7.02B | $7.31B | $7.38B | $8.23B |
| Net income | $-5.07B | $-959.00M | $681.00M | $1.76B | $1.15B | $735.00M | $907.00M | $1.09B |
| Net margin | -35.5% | -6.9% | 4.8% | 11.2% | 6.6% | 4.3% | 5.4% | 6.3% |
Source: Corteva, Inc. SEC filings (10-K).
What growth is priced into CTVA stock?
At today's market cap of $50.17B, Corteva, Inc. is priced for free-cash-flow growth of about 6.1% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $2.81B from the FY ending 2025-12-31). For comparison, free cash flow actually grew 12.1%/yr over the last five fiscal years and revenue 4.1%/yr, computed from its SEC filings. This is a reverse DCF — a translation of the price into a growth assumption you can judge, not a fair value and not advice. Change the assumptions yourself in the interactive view →
Explore 8 years of Corteva, Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track CTVA in your portfolio →
Corteva, Inc. financial history by metric
About Corteva, Inc.
Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. The company was founded in 1802 and is headquartered in Indianapolis, Indiana.
Corteva, Inc. — frequently asked questions
What is Corteva, Inc.'s revenue?
Corteva, Inc. (CTVA) reported revenue of $17.40B for fiscal year 2025, up 2.9% from the prior year, according to its SEC filings.
Is Corteva, Inc. profitable?
Yes. CTVA earned net income of $1.09B in fiscal 2025, a net margin of 6.3%.
What is CTVA's P/E ratio?
Corteva, Inc. trades at a price-to-earnings ratio of about 40.5 based on the latest data in our nightly-refreshed cache.
How fast is Corteva, Inc. growing?
CTVA's revenue grew at roughly 4.1% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does Corteva, Inc. have?
As of fiscal year 2025, CTVA carried roughly $894.00M in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is Corteva, Inc.'s gross margin?
CTVA's gross margin was 47.3% in fiscal 2025 — gross profit of $8.23B on revenue of $17.40B.
What is Corteva, Inc.'s market cap?
Corteva, Inc. (CTVA) has a market capitalization of about $50.17B, based on the latest data in our nightly-refreshed cache.
When does Corteva, Inc.'s fiscal year end?
CTVA's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
What growth is priced into CTVA stock?
At today's market cap of $50.17B, Corteva, Inc. is priced for free-cash-flow growth of about 6.1% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $2.81B from the FY ending 2025-12-31). For comparison, free cash flow actually grew 12.1%/yr over the last five fiscal years and revenue 4.1%/yr, computed from its SEC filings.
Where does this data come from?
All figures are computed from Corteva, Inc.'s official SEC filings (10-K and 10-Q), covering 8 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.